Medical device company Procyrion, Inc. announced on Monday that it has named Lucas Buchanan as a new director.

Buchanan, a MedTech executive and experienced board member, is presently the chief operating officer and chief financial officer at Silk Road Medical. He has served in investment and commercial roles at The Vertical Group, Impax Laboratories, Medtronic and Ernst & Young. Currently, he serves on the board of directors for Endologix and as a strategic advisory board member of CRG LP.

Gary F Burbach, chair of the board of directors, Procyrion, said, 'We are thrilled to have an accomplished leader like Lucas join the Procyrion Board. Lucas' deep industry experience will be an important asset to the board and company as we work together to make the groundbreaking Aortix therapy available for patients with acute decompensated heart failure.'